ARHGAP35 and skin neoplasm: Furthermore, the expression levels of p190RhoGAP are emerged as a prognostic factor in patients with skin cancer and moreover, promising therapeutic strategies are paved for potential targeted therapies against p190RhoGAP which indirectly will suppress ATX in cancer cells.